Welcome to our dedicated page for Sono Tek SEC filings (Ticker: SOTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sono-Tek Corporation (Nasdaq: SOTK) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Sono-Tek is incorporated in New York, and its recent filings include multiple current reports on Form 8-K and a definitive proxy statement on Schedule 14A, all of which help investors understand the company’s operations, governance, and material events.
Recent Form 8-K filings for Sono-Tek cover results of operations and financial condition, including quarterly earnings releases, as well as material orders such as multi-million dollar medical device coating system contracts. Other 8-Ks report on shareholder meeting presentations and voting outcomes, including director elections, auditor ratification, and advisory votes on executive compensation and the frequency of such votes.
The company’s definitive proxy statement (DEF 14A) outlines matters submitted to shareholders at the annual meeting, such as the election of directors and approval of auditors, and provides detail on governance structure and compensation policies. Together with periodic reports not listed here, these filings form the core regulatory record for SOTK.
On Stock Titan, Sono-Tek’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain the key points of lengthy documents, so readers can quickly see what changed in a quarter, how large orders are disclosed, or how shareholder votes were cast. Users can review 8-Ks for earnings and major contracts, proxy materials for governance information, and other filings to build a fuller picture of Sono-Tek’s financial reporting, risk disclosures, and corporate actions.
Sono-Tek Corporation reported that it issued a press release announcing an order for medical device coating systems valued at over $5 million. The company described this order in a report about its results of operations and financial condition and as a Regulation FD disclosure.
The press release, dated September 3, 2025 and attached as an exhibit, provides additional details on the order. The information in this report and the exhibit is being furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws or automatically incorporated into other company reports.
Sono-Tek Corporation shareholders elected four director nominees to serve until the 2026 annual meeting and ratified the appointment of CBIZ CPAs P.C. as independent auditors for the fiscal year ending February 28, 2026. Shareholders also approved, in a non-binding advisory vote, the compensation of the company’s named executive officers and recommended a three-year frequency for future non-binding shareholder votes on executive compensation, which the company accepted.
Lawal Adeniyi, a director of Sono-Tek Corporation (SOTK), reported an options acquisition on Form 4 dated 08/21/2025. The filing shows purchase of 7,018 Sono-Tek options with an exercise price of $3.25, exercisable beginning 08/21/2026 and expiring 08/21/2035, representing 7,018 underlying common shares. After the transaction the reporting person beneficially owns 12,351 shares directly. The Form 4 was filed by one reporting person.
Eric Haskell, a director of Sono-Tek Corporation (SOTK), reported acquiring 7,018 stock options on 08/21/2025 at an exercise price of $3.25 per share. The options become exercisable on 08/21/2026 and expire on 08/21/2035, and they cover 7,018 shares of common stock. Following the reported transaction, Mr. Haskell directly beneficially owns 35,377 shares.
Joseph Riemer, a director of Sono-Tek Corporation (SOTK), reported acquiring 7,018 shares on 08/21/2025 through the exercise of Sono-Tek stock options with an exercise price of $3.25 per share. The options are exercisable beginning 08/21/2026 and expire 08/21/2035. Following the reported transaction, Mr. Riemer beneficially owns 27,377 shares of common stock. The Form 4 was signed on 08/22/2025.
Carol O'Donnell, a director of Sono-Tek Corporation (SOTK), reported acquiring derivative securities on 08/21/2025. The filing shows acquisition of 7,018 Sono-Tek options with a $3.25 exercise price, exercisable beginning 08/21/2026 and expiring 08/21/2035. After the reported transaction, Ms. O'Donnell directly beneficially owned 25,377 shares of common stock. The Form 4 was signed 08/22/2025.
Sono-Tek director Kirk M. Warshaw reported exercising stock options on 08/21/2025, acquiring 7,018 shares of Sono-Tek Corp (SOTK) at an exercise price of $3.25 per share. Following the transaction the reporting person beneficially owns 7,018 shares directly. The Form 4 was signed on 08/22/2025.
Stephen James Bagley, CFO of Sono-Tek Corporation (SOTK), reported an insider acquisition of company options. The Form 4 shows an acquisition dated 08/21/2025 of 12,195 Sono-Tek options with an exercise price of $3.25 each. Those options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Bagley beneficially owns 38,700 shares of Sono-Tek common stock. The form is signed by the reporting person on 08/22/2025.
Christopher Coccio, a director of Sono-Tek Corp (SOTK), reported on Form 4 that on 08/21/2025 he acquired 29,240 stock options at an exercise price of $3.25. The options become exercisable on 08/21/2026 and expire on 08/21/2035, and they cover 29,240 shares of common stock. After the reported transaction, Mr. Coccio beneficially owned 99,744 shares. The filing is signed and dated 08/22/2025.
Maria Kuha, Vice President and director of Sono-Tek Corporation (SOTK), exercised options on 08/21/2025 to acquire 12,195 shares of common stock at an exercise price of $3.25 per share. The options become exercisable on 08/21/2026 and expire 08/21/2035. Following the transaction, Ms. Kuha directly beneficially owns 27,796 shares of Sono-Tek common stock.